Beijing Xinke Sida Pharmaceutical Technology Co., Ltd., was founded in August 2000, occupying a land area of 1,314 square meters. The company produces the radiopharmaceutical lyophilized powder injections all year round. It is managed strictly pursuant to the quality management standards for drug production, and has passed all the inspections of the National Medical Products Administration of China.

 

The company is committed to the in-depth development of the nuclear medicine industry, promotes the development of nuclear medicine, establishes the friendly long-term cooperation with excellent domestic and foreign experts, scientific research institutions, etc., and strengthen the company’s reserves in the future development of products and other aspects. In addition to the production and sales of products, it also provides the relevant technical cooperation and scientific research services, including sale of protective equipment together with the branch.

 

After more than 20 years of efforts and development, the company has become one of the few pharmaceutical companies in China with complete qualifications and deployment in the key areas of the nuclear medicine industry chain. The company is also the China Isotope & Radiation Association Member Unit.

 

With its first-class quality assurance, timely and consideration services, Beijing Xinke Sida has won the praise of domestic customers, and looks forward to going hand in hand with you to develop a better tomorrow of the nuclear medicine!